Menu
Back to Journals » Drug Design, Development and Therapy » Volume 11
Original Research
Efficacy of the dual PI3K and mTOR inhibitor NVP-BEZ235 in combination with imatinib mesylate against chronic myelogenous leukemia cell lines
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 11,253 | Dovepress* | 10,323+ | 1,444 | 11,767 | |
| PubMed Central* | 930 | 345 | 1,275 | ||
| Totals | 11,253 | 1,789 | 13,042 | ||
| *Since 3 April 2017 | |||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 8 | 1 | 0 | 0 | 2 | 5 |
View citations on PubMed Central and Google Scholar